Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Role of aldose reductase in the peritoneal changes of patients undergoing peritoneal dialysis.

Role of aldose reductase in the peritoneal changes of patients undergoing peritoneal dialysis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Role of aldose reductase in the peritoneal changes of patients undergoing peritoneal dialysis. Abstract Text:

    yukiko hasuikeYukiko Hasuike,rintarou moriguchiRintarou Moriguchi,reiko hataReiko Hata,kouji miyagawaKouji Miyagawa,takahiro kuraganoTakahiro Kuragano,masayo aizawaMasayo Aizawa,shigeo yamamotoShigeo Yamamoto,kimihiko yanaseKimihiko Yanase,masaaki izumiMasaaki Izumi,tsuyoshi tanimotoTsuyoshi Tanimoto,takeshi nakanishiTakeshi Nakanishi,yukiko hasuikeYukiko Hasuike,rintarou moriguchiRintarou Moriguchi,reiko hataReiko Hata,kouji miyagawaKouji Miyagawa,takahiro kuraganoTakahiro Kuragano,masayo aizawaMasayo Aizawa,shigeo yamamotoShigeo Yamamoto,kimihiko yanaseKimihiko Yanase,masaaki izumiMasaaki Izumi,tsuyoshi tanimotoTsuyoshi Tanimoto,takeshi nakanishiTakeshi Nakanishi,

    BACKGROUND/AIMS: The mesothelium of patients undergoing peritoneal dialysis (PD) is exposed to glucose in dialysate. Glucose metabolites 3-deoxyglucosone and advanced glycation endproducts (AGEs) in the PD fluid induce peritoneal damage. Circulating factors also affect the peritoneum in the uremic model and predialysis patients. Aldose reductase (AR) generates precursors of 3-deoxyglucosone. We have reported AR acceleration in uremic patients. Therefore, AR acceleration might affect the peritoneum. The purpose of this study was to evaluate the AR level in PD patients and to determine the factors that change the peritoneum of these patients. METHODS: We measured the PD effluent (eff-) concentration of cancer antigen 125 (CA125) as a marker of mesothelial viability in PD patients. Erythrocyte AR, eff-, and plasma (p-) concentrations of 3-deoxyglucosone, AGEs, and malondialdehyde were also studied in 30 PD patients, 18 patients undergoing hemodialysis, and 8 control subjects. RESULTS: In the PD group, AR, p-3-deoxyglucosone, p-AGEs, and p-malondialdehyde were higher than in the control group. The predictors for eff-CA125 were not only PD duration and eff-3-deoxyglucosone, but also AR. CONCLUSION: AR was upregulated in PD patients. AR acceleration may affect the peritoneum in these patients. Further studies are needed to clarify the role of AR in PD patients.

    Role of aldose reductase in the peritoneal changes of patients undergoing peritoneal dialysis. Publishing Authors By Initials

    y hasuikeY Hasuike,r moriguchiR Moriguchi,r hataR Hata,k miyagawaK Miyagawa,t kuraganoT Kuragano,m aizawaM Aizawa,s yamamotoS Yamamoto,k yanaseK Yanase,m izumiM Izumi,t tanimotoT Tanimoto,t nakanishiT Nakanishi,y hasuikeY Hasuike,r moriguchiR Moriguchi,r hataR Hata,k miyagawaK Miyagawa,t kuraganoT Kuragano,m aizawaM Aizawa,s yamamotoS Yamamoto,k yanaseK Yanase,m izumiM Izumi,t tanimotoT Tanimoto,t nakanishiT Nakanishi,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Role of aldose reductase in the peritoneal changes of patients undergoing peritoneal dialysis. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: American journal of nephrology

    VOLUME: 27

    Page Numbers: 622-9

    Journal Abbreviation: Am. J. Nephrol.

    ISSN: 1421-9670

    DAY: 11

    MONTH: 09

    YEAR: 2007

    Role of aldose reductase in the peritoneal changes of patients undergoing peritoneal dialysis. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8109361

    Role of aldose reductase in the peritoneal changes of patients undergoing peritoneal dialysis. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Role of aldose reductase in the peritoneal changes of patients undergoing peritoneal dialysis. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Role of aldose reductase in the peritoneal changes of patients undergoing peritoneal dialysis.

    AFFILIATION: Department of Nephrology and Dialysis, Hyogo College of Medicine, Hyogo, Japan. cherry39@hyo-med.ac.jp

    Country: Switzerland

    Switzerland Research PublicationSwitzerland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Am J Nephrol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Role of aldose reductase in the peritoneal changes of patients undergoing peritoneal dialysis Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News